May 5th 2021, 9:00pm
FDA committee members recently voted in favor of upholding Tecentriq’s accelerated approval indication for the first-line treatment of certain adults with locally advanced or metastatic urothelial carcinoma who are ineligible for standard chemotherapy.
April 22nd 2021, 3:00pm
In this episode of the “CURE® Talks Cancer” podcast, Henry Scowcroft discusses his experiences writing a book about his late wife’s cancer journey and offers advice for other caregivers.
April 13th 2021, 9:00pm
Several factors were associated with patients undergoing radical nephrectomy compared with radical nephroureterectomy including Black race, large tumors, advanced tumor stage and high-grade tumors.
April 13th 2021, 7:37pm
Trodelvy has received accelerated approval from the FDA for the treatment of patients with advanced urothelial cancer.
April 12th 2021, 9:00pm
Adjusting the dose of cisplatin, when added to regular doses of Abraxane and gemcitabine, led to similar survival rates when treating patients with advanced/metastatic urothelial carcinoma, which may help to address issues commonly seen with patients who cannot tolerate cisplatin such as renal dysfunction.
March 9th 2021, 2:00pm
If patients were receiving Tecentriq for prior platinum-based treated metastatic urothelial carcinoma, they should discuss next best steps with their health care providers.
March 4th 2021, 10:00pm
While it is important to educate oneself after receiving a diagnosis of cancer, it’s also critical to know when to step away and find a balance between cancer and life, according to Diane Zipursky-Quale.
February 24th 2021, 10:00pm
To discuss the projected rise in bladder cancer cases in 2021, CURE® spoke with Bladder Cancer Advocacy Network (BCAN) co-founder Diane Zipursky-Quale, who offered some insight on why the numbers continue to rise, and provides some hope in the form of educational programs offered by her organization.
February 15th 2021, 10:00pm
Treatment with Padcev, compared to chemotherapy, continues to show better results in patients with advanced urothelial carcinoma who had previously received certain therapies.
February 15th 2021, 1:00pm
In Episode 2 of the “Bladder Cancer Matters” podcast, host Rick Bangs interviews Dr. Heather Honoré Goltz in Part 2 of a two-part episode.
How Can Cancer Survivors Help The Newly Diagnosed?
CURE Honors World Ovarian Cancer Day
Derazantinib May Demonstrate Promising Disease Control in Some Patients With Cholangiocarcinoma
You May Have Second Thoughts When Receiving a Cancer Diagnosis
